Captivate Bio to offer DenovoMatrix cell culture products in U.S.

By The Science Advisory Board staff writers

April 6, 2021 -- Captivate Bio has signed an agreement with German biotechnology firm DenovoMatrix to become the company's North American distributor of modular, biomimetic cell culture products for the cell therapy and cellular agricultural markets.

Specifically, Captivate Bio will distribute the firm's screenMatrix 96-well microplate system, as well as precoated consumables that promote chemically defined cell adhesion and expansion in serum-free, xeno-free induced pluripotent stem cell (iPSC) and mesenchymal stem cell (MSC) culture applications, according to Captivate Bio.

The DenovoMatrix consumables to be distributed by CaptivateBio will include the products myMatrixMSC and the newly released myMatrixiPSC.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here